<?xml version="1.0" encoding="UTF-8"?>
<p id="p0205">Global pandemics such as COVID-19 will not only expose several bottlenecks in the supply chain in the pharmaceutical industry, but will also collapse the delicate balance that exists between supply and demand at the end-user units. Typically, drug shortages can result from several causes. These include both business and market factors:
 <list list-type="simple" id="ulist0010">
  <list-item id="u0010">
   <label>•</label>
   <p id="p0210">A lack of transparency or communication about actual or probable product shortages</p>
  </list-item>
  <list-item id="u0015">
   <label>•</label>
   <p id="p0215">A lack of business incentives to enter a specific product market</p>
  </list-item>
  <list-item id="u0020">
   <label>•</label>
   <p id="p0220">Unpredictable changes in product demand, such as in the current situation</p>
  </list-item>
  <list-item id="u0025">
   <label>•</label>
   <p id="p0225">A reallocation of production lines</p>
  </list-item>
  <list-item id="u0030">
   <label>•</label>
   <p id="p0230">Consolidation of companies</p>
  </list-item>
 </list>
</p>
